deltatrials
Completed PHASE4 INTERVENTIONAL 2-arm NCT03045133

QUALITY OF RECOVERY AFTER INTRAOPERATIVE MORPHINE OR METHADONE

QUALITY OF RECOVERY AFTER INTRAOPERATIVE MORPHINE OR METHADONE IN PATIENTS UNDERGOING LAPAROSCOPIC CHOLECYSTECTOMY

Sponsor: Pontificia Universidade Catolica de Sao Paulo

Updated 6 times since 2017 Last updated: May 3, 2017 Started: Jun 20, 2016 Primary completion: Jul 20, 2016 Completion: Apr 20, 2017
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Nausea and Vomiting, Postoperative and Pain, Postoperative, this trial is completed. The trial is conducted by Pontificia Universidade Catolica de Sao Paulo and has accumulated 6 data snapshots since 2016. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Feb 2017 – ~Jul 2017 · 5 months · monthly snapshotRecruiting~Jul 2017 – ~Jun 2018 · 11 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

6 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE4

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE4

  5. Jul 2017 — Jun 2018 [monthly]

    Completed PHASE4

    Status: RecruitingCompleted

Show 1 earlier version
  1. Feb 2017 — Jul 2017 [monthly]

    Recruiting PHASE4

    First recorded

Jun 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Pontificia Universidade Catolica de Sao Paulo
Data source: Pontificia Universidade Catolica de Sao Paulo

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations